testosterone replacement therapy
Coverage of testosterone replacement therapy in the Nexus archive.
- US Defence Secretary Hegseth announces mandatory testosterone screening for troops 30 years old or above
US Defence Secretary Pete Hegseth announced mandatory annual testosterone screening for troops aged 30 or older to address testosterone deficiency, with voluntary hormone replacement therapy available for those diagnosed. The policy faces criticism from Democrats, who contrast it with Hegseth's prior ban on transgender service members requiring hormone therapy.
- Trump defence chief Hegseth unveils plan to test US troops for low testosterone
US Defence Secretary Pete Hegseth announced a new annual screening programme for testosterone deficiency among troops aged 30 and older, with voluntary testing available for those under 30. The initiative aims to ensure troops operate at their 'absolute best' through testosterone replacement therapy if needed.
- Hegseth announces new policy to test troops for low testosterone
Defense Secretary Pete Hegseth announced annual testosterone deficiency screenings for troops aged 30 and older, with younger troops able to volunteer. The policy aims to maintain troop strength and readiness but lacks specific targeted conditions or research backing. It aligns with broader Trump administration efforts to ease testosterone replacement therapy access.
- Hegseth announces annual testosterone screenings for service members
Defense Secretary Pete Hegseth announced annual testosterone screenings for service members aged 30 and older, including access to testosterone replacement therapy, as part of periodic health assessments aimed at maintaining military lethality.
- Scientists say GLP-1s improved male testosterone levels and sperm count
GLP-1 medications improved testosterone levels, sperm count, and sperm morphology in men after 24 weeks, according to a study led by Dr. Pratibha Natesh. However, experts caution more research is needed before prescribing these drugs for male infertility, noting potential risks from sudden weight loss and metabolic changes.
- Testosterone is being overprescribed to men — here's who should take it, and when it backfires
Testosterone therapy is overprescribed in the US, with 88% of men in a study not meeting criteria for treatment, risking heart issues, infertility, and long-term dependence. The University of Michigan study highlights improper prescriptions to men with conditions like sleep apnea or prostate cancer, as TRT use has quadrupled since the 1990s.
- Daily briefing: Who needs testosterone therapy?
The article discusses testosterone replacement therapy and its benefits and risks for men and women, while also mentioning US lawmakers' rejection of Trump's budget cuts and featuring scientists from Iran. Testosterone therapy is a topic of interest in the medical field. The article covers various topics including science and politics.